Pharsight

Tripoint patents expiration

1. Elepsia Xr patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US8535717 TRIPOINT Pharmaceutical composition
Feb, 2026

(1 year, 10 months from now)

US8425938 TRIPOINT Pharmaceutical composition
Feb, 2026

(1 year, 10 months from now)

US8163306 TRIPOINT Oral drug delivery system
Sep, 2027

(3 years from now)

US8470367 TRIPOINT Oral drug delivery system
Oct, 2027

(3 years from now)

US8431156 TRIPOINT Pharmaceutical composition
Oct, 2027

(3 years from now)

Drugs and Companies using LEVETIRACETAM ingredient

Market Authorisation Date: 20 December, 2018

Treatment: NA

Dosage: TABLET, EXTENDED RELEASE;ORAL

More Information on Dosage

ELEPSIA XR family patents

Family Patents